I

Initial Therapeutics

12 employees

Initial Therapeutics is a developer of small-molecule medicines designed to prevent pathogenic protein synthesis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
biotechnology
drug discovery
Therapeutics
drug development
life sciences
pharmaceuticals
biotech

Date founded

2020

Funding rounds raised

Total raised

$75M

from 2 investors over 2 rounds

I

Initial Therapeutics raised $75M on May 1, 2023

Investors: ATP (Apple Tree Partners)

I

Initial Therapeutics raised $3.8M on July 16, 2020

Investors: ATP (Apple Tree Partners)

FAQ